{"id":8933,"date":"2024-11-14T14:24:00","date_gmt":"2024-11-14T11:24:00","guid":{"rendered":"https:\/\/www.hbrkahta.com\/?p=8933"},"modified":"2024-11-14T14:24:00","modified_gmt":"2024-11-14T11:24:00","slug":"14-kasim-dunya-diyabet-gunu-etkinligi-duzenlendi","status":"publish","type":"post","link":"https:\/\/www.hbrkahta.com\/index.php\/2024\/11\/14\/14-kasim-dunya-diyabet-gunu-etkinligi-duzenlendi\/","title":{"rendered":"&#8217;14 Kas\u0131m D\u00fcnya Diyabet G\u00fcn\u00fc&#8217; etkinli\u011fi d\u00fczenlendi"},"content":{"rendered":"<p>Ad\u0131yaman E\u011fitim ve Ara\u015ft\u0131rma Hastanesi&#8217;nde &#8217;14 Kas\u0131m D\u00fcnya Diyabet G\u00fcn\u00fc&#8217; nedeniyle kurulan bilgilendirme ve e\u011fitim stand\u0131ndaki etkinli\u011fe kat\u0131lan Ad\u0131yaman E\u011fitim ve Ara\u015ft\u0131rma Hastanesi Ba\u015fhekimi Do\u00e7.Dr. Kas\u0131m Turgut&#8217;a Endokrinoloji ve Metabolizma Hastal\u0131klar\u0131 Uzman\u0131 Dr. Yusuf Kayhan, Sa\u011fl\u0131k Bak\u0131m Hizmetleri M\u00fcd\u00fcr\u00fc Fahri Da\u011fhan, Hastane M\u00fcd\u00fcr Yard\u0131mc\u0131lar\u0131 Selim \u00c7\u0131nar, Diyabet Hem\u015fireleri Rahime Ak\u00e7ay ve Elif \u00d6l\u00e7er e\u015flik etti. <br \/>\nBa\u015fhekim Do\u00e7.Dr.Kas\u0131m Turgut, g\u00f6revli hem\u015fireden etkinlik hakk\u0131nda bilgi alarak &#8217;14 Kas\u0131m D\u00fcnya Diyabet G\u00fcn\u00fc&#8217; nedeniyle diyabet \u00f6l\u00e7\u00fcm\u00fc i\u00e7in gelen vatanda\u015flarla sohbet etti.<br \/>\n14 Kas\u0131m D\u00fcnya Diyabet G\u00fcn\u00fc ile ilgili de\u011ferlendirmede bulunan Endokrinoloji ve Metabolizma Hastal\u0131klar\u0131 Uzman\u0131 Dr. Yusuf Kayhan, Diyabet ins\u00fclin direnci, ins\u00fclin eksikli\u011fi, ya da ins\u00fclin diren\u00e7 ve eksikli\u011finin bir arada bulunmas\u0131 durumuna ba\u011fl\u0131 olarak geli\u015fen kan \u015fekerinin y\u00fcksek oldu\u011fu bir hastal\u0131k oldu\u011funu hat\u0131rlatt\u0131.<br \/>\n2019&#8217;da 463 milyon yeti\u015fkin birey, yani 11 yeti\u015fkinden 1\u2019i diyabet oldu\u011funu 2040 y\u0131l\u0131nda ise bu say\u0131n\u0131n 642 milyona ula\u015fmas\u0131 tahmin edildi\u011fini belirten Endokrinoloji ve Metabolizma Hastal\u0131klar\u0131 Uzman\u0131 Dr. Yusuf Kayhan,&#8221;Diyabet hem d\u00fcnyada hem de \u00fclkemizde olduk\u00e7a s\u0131k g\u00f6r\u00fclen ve ne yaz\u0131k ki hayat boyu s\u00fcregelen bir hastal\u0131kt\u0131r. Uluslararas\u0131 Diyabet Federasyonu verilerine g\u00f6re, 2019&#8217;da 463 milyon yeti\u015fkin birey, yani 11 yeti\u015fkinden 1\u2019i diyabetlidir. 2040 y\u0131l\u0131nda bu say\u0131n\u0131n 642 milyona ula\u015faca\u011f\u0131 tahmin edilmektedir. D\u00fcnyada her 10 eri\u015fkinden 1\u2019i, Avrupa k\u0131tas\u0131nda her 11 eri\u015fkinden 1\u2019i diyabetlidir. \u00dclkemizde 1997-1998 y\u0131llar\u0131nda diyabet s\u0131kl\u0131\u011f\u0131 y\u00fczde 7.2 iken 2010 y\u0131l\u0131nda yakla\u015f\u0131k iki kat artarak y\u00fczde 13.7\u2019ye ula\u015ft\u0131\u011f\u0131 g\u00f6r\u00fclm\u00fc\u015ft\u00fcr. T\u00fcrkiye Avrupa\u2019da diyabet s\u0131kl\u0131\u011f\u0131n\u0131n en y\u00fcksek oldu\u011fu ve en fazla diyabetli hastan\u0131n ya\u015fad\u0131\u011f\u0131 \u00fclkelerdendir. Diyabetin d\u00f6rt farkl\u0131 tipi vard\u0131r. Tip 1 (y\u00fczde 5-10), tip 2 (y\u00fczde 80-90), gestasyonel diyabet, di\u011fer nedenlere ba\u011fl\u0131 diyabet (genetik sebepler, e\u015flik eden hastal\u0131klar, ila\u00e7lar).  Diyabet s\u0131k g\u00f6r\u00fclen, kontrol alt\u0131nda tutulmazsa erken ya\u015fta ciddi sa\u011fl\u0131k sorunlar\u0131na ve \u00f6l\u00fcme yol a\u00e7abilen, ya\u015fam kalitesini olumsuz y\u00f6nde etkileyen \u00f6nemli bir halk sa\u011fl\u0131\u011f\u0131 sorunudur. Ya\u015fam boyu izlem ve tedavi gerektirir. Bununla birlikte etkin y\u00f6netildi\u011finde normal ya\u015fam kalitesi ve ya\u015fam s\u00fcresi sa\u011flanabilir. Hastal\u0131\u011f\u0131n \u00f6nlenmesi i\u00e7in \u00e7aba harcanmas\u0131, erken tan\u0131 konmas\u0131 ve uygun bir \u015fekilde tedavi edilmesi gereklidir. Do\u011fru beslenme (t\u0131bbi beslenme tedavisi), fiziksel aktivitenin art\u0131r\u0131lmas\u0131 ve ila\u00e7lar tedavinin temellerini olu\u015fturur.&#8221;dedi.<br \/>\nKronik hastal\u0131kta hastan\u0131n uyumunun tedavi etkinli\u011fini artt\u0131rd\u0131\u011f\u0131 a\u015fik&acirc;r olsa da diyabet kadar y\u00f6netim ve tedavi s\u00fcrecine hastan\u0131n birebir dahil oldu\u011fu ikinci bir hastal\u0131k olmad\u0131\u011f\u0131n\u0131 aktaran Kayhan, konu\u015fmas\u0131n\u0131 \u015f\u00f6yle s\u00fcrd\u00fcrd\u00fc:<br \/>\n&#8220;Her t\u00fcrl\u00fc kronik hastal\u0131kta hastan\u0131n uyumunun tedavi etkinli\u011fini artt\u0131rd\u0131\u011f\u0131 a\u015fik&acirc;r olsa da diyabet kadar y\u00f6netim ve tedavi s\u00fcrecine hastan\u0131n birebir dahil oldu\u011fu ikinci bir hastal\u0131k yoktur. Bu ba\u011flamda diyabetli bireylerin e\u011fitimi; erken tan\u0131, tedavi hedeflerine ula\u015fma ve komplikasyon geli\u015fim s\u00fcrecini \u00e7arp\u0131c\u0131 olarak etkilemektedir. E\u011fitim ile diyabetli bireyler bir taraftan kal\u0131c\u0131 ve s\u00fcrd\u00fcr\u00fclebilir ya\u015fam tarz\u0131 de\u011fi\u015fiklikleri konusunda bir taraftan da s\u00fcre\u00e7te geli\u015febilecek ani ve uzun s\u00fcreli sorunlarda erken ve etkili m\u00fcdahale konusunda fark\u0131ndal\u0131klar\u0131 artmaktad\u0131r. <br \/>\nAktif ve etkili e\u011fitim s\u00fcrecine gerek birinci basamak gerek ikinci ve \u00fc\u00e7\u00fcnc\u00fc basamak sa\u011fl\u0131k kurulu\u015flar\u0131nda zaman\u0131n ve fiziksel ortam\u0131n uygun oldu\u011fu her ortamda diyabet hastas\u0131 ile kar\u015f\u0131la\u015fan ve tedavi s\u00fcrecine dahil olan hekim \u00f6nderli\u011finde hem\u015fire ve di\u011fer sa\u011fl\u0131k personelinin dahil olmas\u0131 uzun vadede diyabet y\u00f6netimine olumlu katk\u0131 sa\u011flayacakt\u0131r.<br \/>\nBu bilgiler \u0131\u015f\u0131\u011f\u0131nda Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131&#8217;n\u0131n organizasyonu ile uygun olan her sa\u011fl\u0131k tesisinde oldu\u011fu gibi Ad\u0131yaman \u00dcniversitesi E\u011fitim ve Ara\u015ft\u0131rma Hastanesi&#8217;nde de Diyabet Okulu E\u011fitim Programlar\u0131 ile diyabetli bireylere e\u011fitim verilerek sertifika d\u00fczenlenmektedir.<br \/>\n14 Kas\u0131m, ins\u00fclini ke\u015ffederek diyabet tedavisinde d\u00fcnyada \u00e7\u0131\u011f\u0131r a\u00e7an bilim insan\u0131 Frederick Banting&#8217;in do\u011fum tarihi olup 1991&#8217;den bu yana Birle\u015fmi\u015f Milletler kanal\u0131 ile t\u00fcm d\u00fcnyada oldu\u011fu gibi T\u00fcrkiye&#8217;de de D\u00fcnya Diyabet G\u00fcn\u00fc olarak kutlanmakta ve toplumlarda diyabet fark\u0131ndal\u0131\u011f\u0131n\u0131n artt\u0131r\u0131lmas\u0131n\u0131 ama\u00e7lamaktad\u0131r.&#8221;<br \/>\nProgramda diyabet hem\u015fireleri taraf\u0131ndan standa gelen vatanda\u015flar\u0131n diyabet \u00f6l\u00e7\u00fcm\u00fc yap\u0131larak, bilgilendirmede bulundular.\n <\/p><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Ad\u0131yaman E\u011fitim ve Ara\u015ft\u0131rma  Hastanesi&#8217;nde &#8217;14 Kas\u0131m D\u00fcnya Diyabet G\u00fcn\u00fc&#8217; nedeniyle fark\u0131ndal\u0131k e\u011fitimi d\u00fczenlendi.<\/p>\n","protected":false},"author":1,"featured_media":8934,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[1,11,13],"tags":[540,76,475,1208,420],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.hbrkahta.com\/index.php\/wp-json\/wp\/v2\/posts\/8933"}],"collection":[{"href":"https:\/\/www.hbrkahta.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hbrkahta.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hbrkahta.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hbrkahta.com\/index.php\/wp-json\/wp\/v2\/comments?post=8933"}],"version-history":[{"count":1,"href":"https:\/\/www.hbrkahta.com\/index.php\/wp-json\/wp\/v2\/posts\/8933\/revisions"}],"predecessor-version":[{"id":8935,"href":"https:\/\/www.hbrkahta.com\/index.php\/wp-json\/wp\/v2\/posts\/8933\/revisions\/8935"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.hbrkahta.com\/index.php\/wp-json\/wp\/v2\/media\/8934"}],"wp:attachment":[{"href":"https:\/\/www.hbrkahta.com\/index.php\/wp-json\/wp\/v2\/media?parent=8933"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hbrkahta.com\/index.php\/wp-json\/wp\/v2\/categories?post=8933"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hbrkahta.com\/index.php\/wp-json\/wp\/v2\/tags?post=8933"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}